GlaxoSmithKline begins healthy volunteer study with GSK-3882347 for urinary tract infections Sep. 10, 2020
An integrated pipeline for rapid discovery and validation of MAbs against viral pathogens Sep. 8, 2020
Phase III study evaluates NA-831 plus OPV as prevention and treatment of early onset of COVID-19 Sep. 8, 2020
SH-229: phase II data in combination with daclatasvir in Chinese patients with chronic HCV Sep. 8, 2020
RSS